PRESS RELEASES

Year
December 21 | 2017
FLX Bio Completes $60 Million Series C Financing
November 27 | 2017
FLX Bio to Present at Evercore ISI 2017 Biopharma Catalyst/Deep Dive Conference
September 21 | 2017
FLX Bio Selects Immuno-Oncology Clinical Candidate
May 31 | 2017
FLX Bio Adds Distinguished Immuno-Oncology Experts to its Scientific Advisory Board
March 31 | 2017
FLX Bio to Present Poster at the American Association of Cancer Research (AACR) Conference on its Lead Immuno-Oncology Program Targeting CCR4